// App-Quantinova.ai

E023 : The use of CXCl13 as a biomarker in rheumatoid arthritis: a systematic review

Researchers

Presenter

  • Anthony H Dalrymple

Principal Investigators

  • Charles Southey-Bassols

  • Katie Bechman

  • James Galloway

Medical Centers

  • Rheumatology, King’s College London, London, UK

  • Academic Rheumatology and Health Psychology Department, King's College London, London, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

  • Rheumatoid arthritis

Biomarkers

  • C-X-C Motif Chemokine Ligand 13

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved